159 related articles for article (PubMed ID: 37330328)
21. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
[TBL] [Abstract][Full Text] [Related]
22. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy.
Yadav P; Musunuru HB; Witt JS; Bassetti M; Bayouth J; Baschnagel AM
Radiol Oncol; 2019 Sep; 53(3):362-368. PubMed ID: 31553704
[TBL] [Abstract][Full Text] [Related]
25. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
[TBL] [Abstract][Full Text] [Related]
27. Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions - dosimetric impact and how to detect its extent in advance.
Buchele C; Renkamp CK; Regnery S; Behnisch R; Rippke C; Schlüter F; Hoegen-Saßmannshausen P; Debus J; Hörner-Rieber J; Alber M; Klüter S
Radiat Oncol; 2024 Jun; 19(1):80. PubMed ID: 38918828
[TBL] [Abstract][Full Text] [Related]
28. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
[TBL] [Abstract][Full Text] [Related]
29. Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer.
Bai X; Shan G; Chen M; Wang B
Biomed Eng Online; 2019 Oct; 18(1):101. PubMed ID: 31619263
[TBL] [Abstract][Full Text] [Related]
30. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
[TBL] [Abstract][Full Text] [Related]
32. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
[TBL] [Abstract][Full Text] [Related]
33. Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.
Han C; Sampath S; Schultheisss TE; Wong JYC
Med Dosim; 2017 Summer; 42(2):116-121. PubMed ID: 28433482
[TBL] [Abstract][Full Text] [Related]
34. Effects of magnetic field orientation and strength on the treatment planning of nonsmall cell lung cancer.
Schrenk O; Spindeldreier CK; Burigo LN; Hoerner-Rieber J; Pfaffenberger A
Med Phys; 2017 Dec; 44(12):6621-6631. PubMed ID: 29064573
[TBL] [Abstract][Full Text] [Related]
35. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
36. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
[TBL] [Abstract][Full Text] [Related]
37. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
38. MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients.
Eze C; Lombardo E; Nierer L; Xiong Y; Niyazi M; Belka C; Manapov F; Corradini S
Radiat Oncol; 2022 Feb; 17(1):43. PubMed ID: 35209922
[TBL] [Abstract][Full Text] [Related]
39. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]